Switch to optionsXpress for advanced derivatives trading & earn 50 commission-free trades.
Advertisement
SureTrader Stock Hero Advertisement SPDR Advertisement
Home > Boards > US Listed > Medical - Equipment > Navidea Biopharmaceuticals, Inc. (NAVB)

The old timers on IV sometimes have rose

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
sts66 Member Profile
 
Followed By 27
Posts 4,344
Boards Moderated 0
Alias Born 04/26/10
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/30/2015 4:35:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/30/2015 4:28:26 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/30/2015 4:25:58 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/30/2015 4:22:50 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/30/2015 4:20:18 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/30/2015 4:16:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/30/2015 4:15:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/30/2015 4:13:44 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/30/2015 3:53:47 PM
Navidea Biopharmaceuticals Announces Presentation of Lymphoseek® Data at Society of Surgical Oncology Meeting "Business Wire" - 3/25/2015 7:30:00 AM
Macrophage Therapeutics to Expand Efforts Into CNS Diseases "Business Wire" - 3/20/2015 3:11:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/19/2015 3:58:58 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/16/2015 3:07:57 PM
Macrophage Therapeutics, a Subsidiary of Navidea Biopharmaceuticals, Executes Securities Purchase Agreement for $2.5 Million ... "Business Wire" - 3/13/2015 3:29:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/11/2015 4:37:53 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/6/2015 11:25:57 AM
CLARIFICATION of Navidea Announces Fourth Quarter and Full Year 2014 Results "Business Wire" - 3/5/2015 8:58:00 AM
Navidea Announces Fourth Quarter and Full Year 2014 Results "Business Wire" - 3/5/2015 7:30:00 AM
Navidea and Norgine Enter European Commercial Partnership for Lymphoseek®; Navidea to Receive $2 Million Upfront Payment "Business Wire" - 3/5/2015 7:15:00 AM
Macrophage Therapeutics, a Subsidiary of Navidea Biopharmaceuticals, Appoints Leading Experts to Therapeutics-Focused Scienti... "Business Wire" - 2/27/2015 7:30:00 AM
Navidea Biopharmaceuticals to Announce Fourth Quarter and Year-End 2014 Financial Results on March 5, 2015 "Business Wire" - 2/26/2015 7:30:00 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 2/20/2015 5:03:40 PM
Lymphoseek® Data Presented in European Medical Conference Reinforces Clinical Value in Head & Neck Cancer of the Oral Cavity "Business Wire" - 2/18/2015 10:53:00 AM
Lymphoseek® Results from Phase 3 Clinical Trial in Oral Cavity Cancer of the Head & Neck Published in Annals of Surgical Onc... "Business Wire" - 2/17/2015 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/9/2015 4:47:45 PM
sts66   Wednesday, 04/24/13 08:06:49 PM
Re: hondadriver1973 post# 3569
Post # of 7789 
The old timers on IV sometimes have rose colored glasses on....they refuse to see manipulation.....being shorted by firms supposedly investing in NAVB....even the words "basher" or similar are not allowed by DDB....this just doesn't smell right to me.....and JPM apparently bought some for a 2nd unnamed investor again, same thing as last time....who are these mystery buyers and why are their names being kept a secret?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist